Safety, Tolerability, and Immunogenicity of mRNA-4157 Alone and in Combination in Participants With Solid Tumors
Clinical trial NCT03313778 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03313778
- Sponsor
- ModernaTX, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-14
- Primary completion
- 2027-11-21
- Enrollment
- 161
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.